Massachusetts H1227 mandates coverage for biomarker testing in insurance policies.

Massachusetts H1227 requires insurance policies to cover biomarker testing for residents and employees within the state. This includes individual and group health plans, Medicaid, and Medicare. Biomarker testing, defined as the analysis of a patient's tissue, blood, or other biospecimen for biomarkers, must be covered for diagnosis, treatment, management, or monitoring of diseases. The bill mandates timely responses to coverage requests and provides a process for exceptions to coverage policies.

Massachusetts H1227 mandates coverage for biomarker testing in insurance policies.

Massachusetts H1227 requires insurance policies to cover biomarker testing for residents and employees within the state. This includes individual and group health plans, Medicaid, and Medicare. Biomarker testing, defined as the analysis of a patient's tissue, blood, or other biospecimen for biomarkers, must be covered for diagnosis, treatment, management, or monitoring of diseases. The bill mandates timely responses to coverage requests and provides a process for exceptions to coverage policies.